Free Cash Flow Build Up

Orphazyme A/S (ORPH)

$ 4.51
-0.06 -1.31%
Year
A/P
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue ----------
EBITDA ----------
EBIT ----------
Tax Rate 8.67%4.18%2.34%1.60%0.30%3.42%3.42%3.42%3.42%3.42%
EBIAT ----------
Depreciation ----------
Accounts Receivable ----------
Inventories ----------
Accounts Payable ----------
Capital Expenditure -0.24-1.49-2.35-3.29-5.10-----
UFCF ----------
WACC
PV UFCF ----------
SUM PV UFCF -